Ellen Goldberg
Directeur/Membre du Conseil chez CASTLE BIOSCIENCES, INC.
Fortune : 185 443 $ au 30/04/2024
Postes actifs de Ellen Goldberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
CASTLE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 16/07/2021 | - |
Independent Dir/Board Member | 16/07/2021 | - |
Historique de carrière de Ellen Goldberg
Anciens postes connus de Ellen Goldberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Sales & Marketing | 01/01/2009 | 01/01/2011 |
Formation de Ellen Goldberg
Stanford University | Graduate Degree |
Yale University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Graduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CASTLE BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Crescendo Bioscience LLC
Crescendo Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA. | Commercial Services |
- Bourse
- Insiders
- Ellen Goldberg
- Expérience